Significados de base therapeutics em inglês

The Company focuses on the discovery and development of monoclonal antibody- based therapeutics.

Consequently, identifying genes that modify SVAS offers the potential for novel modifier- based therapeutics.

These nonstandard dual-specific antibodies were recently shown to be promising for new antibody- based therapeutics.

From genome- based therapeutics and diagnostics to pulse-monitoring smart watches, health data is transforming medicine.

Stem cell- based therapeutics have become a vital component in tissue engineering and regenerative medicine.

This supports a role for NO- based therapeutics for SCD vasculopathy.

Therapeutic strategies could include immune modulators and microbiome- based therapeutics to reduce this significant health burden.

The impact of NPAAs in the development of peptide- based therapeutics is reviewed in this article.

The present work demonstrates the feasibility of gene editing- based therapeutics toward monogenic diseases such as CF.

Despite certain challenges, Wnt- based therapeutics for CRC emerge continuously and some are now in clinical trials.

Significant progress has been made during the past decade towards the clinical adoption of cell- based therapeutics.

Overall, the optimization of treatment strategies is crucial for successful applications of EVs- based therapeutics for BD.

Cell based therapeutics are emerging as powerful regimens.

Antibody- based therapeutics are powerful tools to treat disease.

Overall, this targeted UVPD approach represents a promising new strategy for the comprehensive characterization of antibody- based therapeutics.

In recent years, there have been major advances in the development of novel nanoparticle- and microparticle- based therapeutics.